Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

2.

Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).

Miyake Y, Nishimura J, Kato T, Ikeda M, Tsujie M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).

Surg Today. 2018 Jan;48(1):66-72. doi: 10.1007/s00595-017-1555-1. Epub 2017 Jun 20.

PMID:
28634730
3.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.

Shimomura Y, Takaki A, Wada N, Yasunaka T, Ikeda F, Maruyama T, Tamaki N, Uchida D, Onishi H, Kuwaki K, Nakamura S, Nouso K, Miyake Y, Koike K, Tomofuji T, Morita M, Yamamoto K, Okada H.

Intern Med. 2017;56(3):243-251. doi: 10.2169/internalmedicine.56.7002. Epub 2017 Feb 1.

4.

Tumor Size as an Independent Risk Factor for Postoperative Complications in Laparoscopic Low Anterior Resection for Advanced Rectal Cancer: A Multicenter Japanese Study.

Yasui M, Takemasa I, Miyake Y, Hata T, Ikeda M, Miyake Y, Hasegawa J, Ota H, Matsuda C, Mizushima T, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group.

Surg Laparosc Endosc Percutan Tech. 2017 Apr;27(2):98-103. doi: 10.1097/SLE.0000000000000377.

PMID:
28141746
5.

[Three Cases of Gastric Cancer with Rare Presentation of Oncologic Emergency].

Oka Y, Okada K, Miyake Y, Ueshima S, Higaki N, Hayashida H, Nezu R.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2398-2400. Japanese.

PMID:
28133334
6.

Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.

Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M.

Hum Mol Genet. 2017 Feb 1;26(3):650-659. doi: 10.1093/hmg/ddw406.

PMID:
28062665
7.

Safety and efficacy of an "enhanced recovery after surgery" protocol for patients undergoing colon cancer surgery: a multi-institutional controlled study.

Ota H, Ikenaga M, Hasegawa J, Murata K, Miyake Y, Mizushima T, Hata T, Takemasa I, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M.

Surg Today. 2017 Jun;47(6):668-675. doi: 10.1007/s00595-016-1423-4. Epub 2016 Sep 29.

PMID:
27688031
8.

Influence of previous abdominal surgery on surgical outcomes between laparoscopic and open surgery in elderly patients with colorectal cancer: subanalysis of a large multicenter study in Japan.

Yamamoto S, Hinoi T, Niitsu H, Okajima M, Ide Y, Murata K, Akamoto S, Kanazawa A, Nakanishi M, Naitoh T, Kanehira E, Shimamura T, Suzuka I, Fukunaga Y, Yamaguchi T, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery.

J Gastroenterol. 2017 Jun;52(6):695-704. doi: 10.1007/s00535-016-1262-5. Epub 2016 Sep 20.

PMID:
27650199
9.

A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).

Yoshida M, Takagane A, Miyake Y, Shimada K, Nagata N, Sato A, Ogata Y, Fukunaga M, Otsuka K, Takahashi T, Matsumoto H, Kagimura T, Tsuji A.

Oncology. 2016;91(1):24-30. doi: 10.1159/000446372. Epub 2016 May 28.

10.

Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.

Uchida D, Takaki A, Ishikawa H, Tomono Y, Kato H, Tsutsumi K, Tamaki N, Maruyama T, Tomofuji T, Tsuzaki R, Yasunaka T, Koike K, Matsushita H, Ikeda F, Miyake Y, Shiraha H, Nouso K, Yoshida R, Umeda Y, Shinoura S, Yagi T, Fujiwara T, Morita M, Fukushima M, Yamamoto K, Okada H.

Free Radic Res. 2016 Jul;50(7):732-43. doi: 10.3109/10715762.2016.1172071. Epub 2016 Apr 25.

PMID:
27021847
11.

Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial.

Yamamoto H, Murata K, Fukunaga M, Ohnishi T, Noura S, Miyake Y, Kato T, Ohtsuka M, Nakamura Y, Takemasa I, Mizushima T, Ikeda M, Ohue M, Sekimoto M, Nezu R, Matsuura N, Monden M, Doki Y, Mori M.

Clin Cancer Res. 2016 Jul 1;22(13):3201-8. doi: 10.1158/1078-0432.CCR-15-2199. Epub 2016 Feb 1.

12.

[Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].

Miyake Y, Ikeda K, Murakami M, Oka Y, Nezu R, Kurokawa E, Kikkawa N.

Gan To Kagaku Ryoho. 2015 Dec;42 Suppl 1:75-8. Review. Japanese.

PMID:
26809419
13.

[The Current Status of Palliative Care for Patients with Advanced Cancer in Nishinomiya City].

Moriyama M, Miyake Y, Kishimoto M, Matsuda M, Oka Y, Ogawa H, Ikeda T, Nezu R.

Gan To Kagaku Ryoho. 2015 Dec;42 Suppl 1:9-10. Japanese.

PMID:
26809397
14.

[A Case of Successful Treatment of Metachronous Liver Metastasis from Gastric Cancer with Hepatectomy].

Okada K, Oka Y, Miyake Y, Nakane S, Ueshima S, Higaki N, Hayashida H, Nezu R.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1995-7. Japanese.

PMID:
26805242
15.

Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer.

Adachi T, Hinoi T, Kinugawa Y, Enomoto T, Maruyama S, Hirose H, Naito M, Tanaka K, Miyake Y, Watanabe M.

J Gastroenterol. 2016 Aug;51(8):779-87. doi: 10.1007/s00535-015-1147-z. Epub 2015 Dec 10.

PMID:
26660524
16.

Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.

Munemoto Y, Kanda M, Ishibashi K, Hata T, Kobayashi M, Hasegawa J, Fukunaga M, Takagane A, Otsuji T, Miyake Y, Nagase M, Sakamoto J, Matsuoka M, Oba K, Mishima H.

BMC Cancer. 2015 Oct 24;15:786. doi: 10.1186/s12885-015-1712-0.

17.

OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan.

Yamamoto H, Tomita N, Inomata M, Furuhata T, Miyake Y, Noura S, Kato T, Murata K, Hayashi S, Igarashi S, Itabashi M, Kameoka S, Matsuura N.

Ann Surg Oncol. 2016 Feb;23(2):391-6. doi: 10.1245/s10434-015-4880-x. Epub 2015 Oct 5.

PMID:
26438440
18.

Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.

Nanba S, Ikeda F, Baba N, Takaguchi K, Senoh T, Nagano T, Seki H, Takeuchi Y, Moritou Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Iwasaki Y, Yamamoto K.

J Clin Pathol. 2016 Mar;69(3):226-33. doi: 10.1136/jclinpath-2015-203215. Epub 2015 Aug 19.

PMID:
26290259
19.

Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.

Seki H, Ikeda F, Nanba S, Moritou Y, Takeuchi Y, Yasunaka T, Onishi H, Miyake Y, Takaki A, Nouso K, Iwasaki Y, Nakamura M, Yamamoto K.

Acta Med Okayama. 2015;69(3):137-44.

20.

Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.

Nishimura J, Satoh T, Fukunaga M, Takemoto H, Nakata K, Ide Y, Fukuzaki T, Kudo T, Miyake Y, Yasui M, Morita S, Sakai D, Uemura M, Hata T, Takemasa I, Mizushima T, Ohno Y, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).

Eur J Cancer. 2015 Jul;51(10):1274-82. doi: 10.1016/j.ejca.2015.03.024. Epub 2015 Apr 24.

PMID:
25922233

Supplemental Content

Loading ...
Support Center